DJ Biogen Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ slipped 1.28% to $157.94 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.39% to 5,893.62 and the Dow Jones Industrial Average falling 0.13% to 43,389.60.
This was the stock's ninth consecutive day of losses.
Biogen Inc. closed $110.36 short of its 52-week high ($268.30), which the company reached on January 3rd.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ rose 0.50% to $154.77 and Pfizer Inc. $(PFE)$ rose 0.24% to $24.86.
Trading volume (1.6 M) eclipsed its 50-day average volume of 1.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 18, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
November 18, 2024 17:07 ET (22:07 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments